<DOC DOCNO="nw/wsj/20/wsj_2099@2099@wsj@nw@en@on">
<ENAMEX TYPE="ORG">Unilab Corp.</ENAMEX> , <ENAMEX TYPE="GPE">Norcross</ENAMEX> , <ENAMEX TYPE="GPE">Ga.</ENAMEX> , said it acquired the clinical laboratories of closely held <ENAMEX TYPE="ORG">Central Diagnostic Laboratory Inc.</ENAMEX> in a cash and securities transaction valued at <ENAMEX TYPE="MONEY">$ 85 million</ENAMEX> .
<ENAMEX TYPE="ORG">Unilab</ENAMEX> said its wholly owned <ENAMEX TYPE="ORG">MetWest Inc.</ENAMEX> unit paid <ENAMEX TYPE="MONEY">$ 25 million</ENAMEX> in cash , provided <ENAMEX TYPE="MONEY">$ 30 million</ENAMEX> in notes and <ENAMEX TYPE="MONEY">$ 30 million</ENAMEX> in preferred stock to acquire <ENAMEX TYPE="ORG">Central</ENAMEX> 's labs in <ENAMEX TYPE="LOC">the Western U.S.</ENAMEX> .
<ENAMEX TYPE="ORG">Unilab</ENAMEX> , which provides clinical laboratory services , competed with <ENAMEX TYPE="ORG">Central</ENAMEX> , based in <ENAMEX TYPE="GPE">Tarzana</ENAMEX> , <ENAMEX TYPE="GPE">Calif.</ENAMEX> , in a number of areas .
Beyond removing a competitor , the combination should provide `` synergies , '' said <ENAMEX TYPE="PERSON">Fred Harlow</ENAMEX> , <ENAMEX TYPE="ORG">Unilab</ENAMEX> 's chief financial officer .
It also will hand <ENAMEX TYPE="ORG">Unilab</ENAMEX> new markets .
In <ENAMEX TYPE="GPE">Los Angeles</ENAMEX> , for example , <ENAMEX TYPE="ORG">Central</ENAMEX> has had a strong market position while <ENAMEX TYPE="ORG">Unilab</ENAMEX> 's presence has been less prominent , according to Mr. <ENAMEX TYPE="PERSON">Harlow</ENAMEX> .
</DOC>
